Rosalind Advisors’s Lyra Therapeutics LYRA Stock Holding History

Rosalind Advisors’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$286K	Sell
2024 Q1	$7.12M	Sell
2023 Q4	$9.9M	Buy